--- title: 'Family Access Manager (FAM), Skeletal Dysplasia - SOUTH EAST at BridgeBio Pharma' canonical: 'https://feeny.ai/job/family-access-manager-fam-skeletal-dysplasia-south-east-bridgebio-pharma-united-s8j14mgc07nz' type: 'job' last_seen: '2026-09-16' --- # Family Access Manager (FAM), Skeletal Dysplasia - SOUTH EAST at BridgeBio Pharma - **Company:** BridgeBio Pharma - **Location:** United States - **Compensation:** $185k–$230k - **Work type:** remote - **Posted:** 2026-09-15 - **Last confirmed live:** 2026-09-16 - **Apply:** https://job-boards.greenhouse.io/bridgebio/jobs/5237981007 ## Job description Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. ## What You'll Do BridgeBio is looking for a Family Access Manager (FAM) in the Southeast region to engage with families/care partners on access, affordability, and reimbursement process for BridgeBio's portfolio of commercialized asset treating skeletal dysplasia. Reporting to the Director of Family Access Managers, this individual will be responsible for engaging with families/care partners and cross-functional teams. The Family Access Manager will play a critical Commercial role in support of infigratinib. The primary goal will be to educate families/care partners on access, affordability, and reimbursement process, build family support program awareness, and execute on all new product launch activities. The Family Access Manager will work collaboratively with the Director of Family Access Managers and internal colleagues to align on the patient services goals and pull through on brand strategies. The ideal candidate should be prepared to work in a fast-paced environment and must be able to collaborate with multiple internal and external stakeholders, including Legal, Compliance, Sales, Marketing, Commercial Analytics, Commercial IT, Training, Pharmacovigilance & Market Access. Additionally, exceptional judgment, business acumen, discretion, communication skills, the ability to empathize, and showing strong relationship-building skills are a must. ## Responsibilities - Provide families/care partner-facing access and affordability support for infigratinib. This requires working closely with the Market Access team, Commercial, Training, and Brand Marketing team - Compliantly ensure a positive patient journey through collaborations with all BridgeBio stakeholders - Lead the evaluation and implementation of family access opportunities within a specific geographic area for all applicable families - Provide face-to-face or via phone, personalized issue resolution, including potential hurdles with access and affordability with families/care partners - Direct access support between consented families and all relevant stakeholders (hub, pharmacies, prescriber’s offices, and support organizations) - Coordinate with the hub partner on missing information follow-ups - Own the relationship between ForgingBridges, a support program offered to families to access the BridgeBio approved medicines, and consented patients - Onboard and welcome new families to the ForgingBridges support program - Manage status changes with ForgingBridges and follow-up with families/care partners, prescriber’s offices, and pharmacies - Ensure ForgingBridges support program business rules are followed - Control the workflow of information and communications with familes - Collaborate with BridgeBio Patient Advocacy team on families/care partners engagements and attend local, regional, and national advocacy meetings/events - Facilitate and present in-person education with families/care partners as requested - Report key insights and findings in a compliant manner to the Brand Marketing and other internal Commercial functions - Follow BridgeBio’s policy on handling protected health information (PHI) obtained through pharmacies, prescriber’s offices, and interactions with families/care partners - As needed, attend Commercial national sales meetings, conferences, and regional events - Work on designated projects that are within the scope of services for Market Access/Patient Support Services as assigned and/or consistent with developmental plans and strengths - Provide strategic and tactical input for continuous improvement purposes - Develop tactical plans (i.e., educating, triaging, hub interactions, etc.) and execute against those plans in support of strategic access imperatives, such as key performance indicators or role metrics as identified by Market Access/Patient Support Services leadership - Additional responsibilities may be assigned - 40-60% domestic travel is required, regionally and intermittently across the US Where You'll Work The ideal candidate would reside in Atlanta, Fort Lauderdale or Miami. ## Who You Are - BA/BS degree is preferred - Minimum of 5-8 years of Biotech/Pharma experience. Patient services, Market Access, and hub experience preferred - Rare Disease experience is preferred - Strong communication and interpersonal skills - Ability to work independently and in a team environment - Demonstrate confidence in building rapport with families/care partners - Must have a strong foundation and experience working closely with patient support programs including copay, cost sharing programs, affordability design, and hub models for medical and pharmacy benefit products - Comprehend the complex environment of the specialty market, buy and bill, retail market, reimbursement/access challenges, as well as the OIG/CMS/legal guidelines for offering patient support programs - Demonstrate excellent analytical skills and the ability to develop sound strategies and tactics for patient access - Exhibit superior communication (oral and written) and teamwork skills to effectively contribute across cross-functional teams - Previous FAM/PAL experience is a plus - Extremely detail oriented to create and manage program documents - Experience establishing and maintaining high-level relationships with families, patients, and key decision-makers ## #LI-TB1 At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Below is the anticipated salary range for candidates for this role who will work in California. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. BridgeBio is a multi-state employer, and this salary range may not reflect positions based in other states. Salary $185,000—$230,000 USD As a global company, our comprehensive benefits may vary based on location.  We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return. For BridgeBio Full-Time U.S Based Roles: Financial & Rewards - Market-leading compensation - 401(k) with employer match - Employee Stock Purchase Program (ESPP) - Pre-tax commuter benefits (transit and parking) - Referral bonus for hired candidates - Subsidized lunch and parking on in-office days Health & Well-Being - 100% employer-paid medical, dental, and vision premiums for you and your dependents - Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA) - Fertility & family-forming benefits - Expanded mental health support (therapy and coaching resources) - Hybrid work model with flexibility - Flexible, “take-what-you-need” paid time off and company-paid holidays - Comprehensive paid medical and parental leave to care for yourself and your family Skill Development & Career Paths: - People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility - We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, & BetterUp Coaching - We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities ## About BridgeBio Pharma ## Company Overview - **One-liner**: BridgeBio Pharma develops transformative medicines for genetic conditions, using a decentralized hub-and-spoke model to accelerate drug development from early research to commercialization. - **Entity Type**: Public (Nasdaq: BBIO) - **Headquarters**: Palo Alto, California, USA (with hybrid offices in San Francisco, CA) - **Founded**: Not explicitly stated in provided sources; the company references “over the past 10 years” as of 2026, suggesting founding around 2015–2016. - **Founders**: Not publicly available from provided sources. ## Core Business - **Primary industry**: Biotechnology / Genetic disease therapeutics - **Target customers**: Patients living with genetic conditions, healthcare providers, payers, and academic research partners - **Mission**: “To develop transformative medicines for genetic conditions” and “bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations.” ## Products & Services BridgeBio’s pipeline includes both approved therapies and investigational candidates across dozens of indications. Key offerings: - **Acoramidis**: Approved for transthyretin amyloidosis (ATTR) – a first-in-class treatment with $8B+ peak year sales potential. - **Infigratinib**: Phase 3 completed for achondroplasia; published in the *New England Journal of Medicine* (2026). - **BBP-418**: Investigational for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9). - **Encaleret**: Investigational for Autosomal Dominant Hypocalcemia Type 1 (ADH1). - **BBP-812**: Investigational for Canavan Disease. - **BridgeBio Oncology Therapeutics (BBOT)**: Subsidiary focused on RAS and PI3Kα-driven cancers. - **GondolaBio**: Subsidiary developing bioavailable small molecule inhibitors for oncology. - **Other programs**: Covering hypochondroplasia, chronic hypoparathyroidism, and more. The company has received **3 FDA approvals** and has over **70+ peer-reviewed publications**. ## Market Standing - **Valuation / Market Cap**: Not explicitly stated in provided data; as a public company, current market cap can be found on financial platforms (e.g., ~$8B based on peak sales potential, but not a direct valuation number). - **Key Metric**: **3 FDA-approved medicines**; **2000+ patients enrolled** in global clinical trials; **6 Phase 3 trials** conducted over the past 10 years. - **Notable Investors / Partners**: Not detailed in provided sources, but the company partners with leading academic institutions to advance early-stage research. - **Growth Signals**: Recent publication of Phase 3 PROPEL 3 trial results in NEJM (June 2026); expansion into oncology via BBOT and GondolaBio; 100% of pipeline is first-in-class or best-in-class; 48 unique disease indications targeted. ## Competitive Advantages - **Hub-and-spoke model**: Decentralized structure where autonomous affiliate teams (spokes) focus on specific conditions, while a central hub provides clinical, regulatory, and commercial expertise. This enables speed, scalability, and risk reduction. - **First-in-class / best-in-class focus**: 100% of pipeline aims to be first or best in class, targeting underserved genetic conditions with clear biological rationale. - **Speed and adaptability**: The model allows rapid pivoting to the most promising opportunities, reducing development timelines compared to traditional biotech. - **Strong scientific foundation**: Over 70 peer-reviewed papers and collaborations with top academic institutions. ## Strategic Focus - **Advance late-stage pipeline**: Prioritize Phase 3 programs (e.g., infigratinib for achondroplasia, acoramidis for ATTR) and seek additional FDA approvals. - **Expand into oncology**: Leverage subsidiaries BBOT and GondolaBio to address RAS/PI3Kα-driven cancers. - **Maintain urgency**: “Every minute counts” – continue to operate with speed and autonomy to bring treatments to patients faster. - **Build on commercial success**: Leverage existing approved products to fund further R&D and expand global reach. ## Why Work Here - **Award-winning culture**: Named **#1 Best Place to Work** by BioSpace (2026, small biotech category) with an **88% employee engagement score** in 2025. - **Flexible work model**: Hybrid policy with offices in San Francisco and Palo Alto, CA; “flexible working model” emphasized. - **Compensation and benefits**: Market-leading pay, comprehensive healthcare, and strong emphasis on growth and internal mobility. - **Impact-driven mission**: Work on transformative treatments for genetic conditions where patient need is urgent – “Impatient for Patients” is a core mantra. - **Values**: Put patients first, let science speak, think independently, speak up, and act with urgency. The culture is described as “high on standards, low on convention.” - **Growth opportunities**: 113 open jobs (as of mid-2026) across functions including clinical, regulatory, manufacturing, commercial, and corporate; talent community available for future roles. ## Sources 1. [bridgebio.com](https://bridgebio.com/) – Home page with pipeline overview and $8B peak sales potential 2. [bridgebio.com/about](https://bridgebio.com/about) – Company description, hub-and-spoke model, and key metrics 3. [bridgebio.com/careers](https://bridgebio.com/careers) – Careers page with awards, culture, and benefits 4. [investor.bridgebio.com](https://investor.bridgebio.com/overview/default.aspx) – Investor relations overview, latest news, and corporate presentation 5. [job-boards.greenhouse.io/bridgebio](http://job-boards.greenhouse.io/bridgebio) – Current job listings (113 roles) and departmental categories ## Other roles at BridgeBio Pharma - [Director, Regulatory CMC](https://feeny.ai/job/director-regulatory-cmc-bridgebio-pharma-united-states-ebrxcpgtzc77) — United States - [Sr. Director/ Exec. Director- CMC, Drug Product](https://feeny.ai/job/sr-director-exec-director-cmc-drug-product-bridgebio-pharma-san-francisco-q4qjnhbq8gr4) — San Francisco, CA - [Family Access Manager (FAM), Skeletal Dysplasia - EAST](https://feeny.ai/job/family-access-manager-fam-skeletal-dysplasia-east-bridgebio-pharma-united-states-jy27te2gkqcf) — United States - [Family Access Manager (FAM), Skeletal Dysplasia - MID-ATLANTIC](https://feeny.ai/job/family-access-manager-fam-skeletal-dysplasia-mid-atlantic-bridgebio-pharma-prrt1cr049ev) — United States - [Family Access Manager (FAM), Skeletal Dysplasia - MIDWEST](https://feeny.ai/job/family-access-manager-fam-skeletal-dysplasia-midwest-bridgebio-pharma-united-7cm4g2xyrx8d) — United States - [Family Access Manager (FAM), Skeletal Dysplasia - South West](https://feeny.ai/job/family-access-manager-fam-skeletal-dysplasia-south-west-bridgebio-pharma-united-cnw8gmc9bmtp) — United States - [Family Access Manager (FAM), Skeletal Dyplasia - WEST](https://feeny.ai/job/family-access-manager-fam-skeletal-dyplasia-west-bridgebio-pharma-united-states-v27ht06awxjg) — United States - [Senior Manager, Computer System Validation QA](https://feeny.ai/job/senior-manager-computer-system-validation-qa-bridgebio-pharma-united-states-8gk11e5n2xrb) — United States - [Associate Director, HCP Marketing](https://feeny.ai/job/associate-director-hcp-marketing-bridgebio-pharma-san-francisco-141ggr9213nb) — San Francisco, CA - [Medical Director, Clinical Science](https://feeny.ai/job/medical-director-clinical-science-bridgebio-pharma-united-states-bnevf5whdv71) — United States